Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

implantable pacemaker Pulse-generator

PMA Number: P950029 · 2025-07-23

ApplicantMicroPort CRM USA, Inc.
Decision Date2025-07-23
PMA NumberP950029
Product CodeDXY
Device ClassClass 3
Medical SpecialtyC
Regulation Number21 CFR 8
Advisory CommitteeCV

Device Summary

implantable pacemaker Pulse-generator is the device name listed in this FDA 510(k) record. The listed applicant is MicroPort CRM USA, Inc.. It received FDA 510(k) clearance on 2025-07-23. The device is classified under product code DXY. It was reviewed by the CV advisory panel. Product code DXY falls under the category of Clinical Chemistry, which covers reagents and instruments for chemical analysis of clinical samples. Devices in this category are subject to specific FDA regulatory requirements.

Frequently Asked Questions

What is the implantable pacemaker Pulse-generator?

implantable pacemaker Pulse-generator is a medical device that received FDA 510(k) clearance on 2025-07-23. The listed applicant is MicroPort CRM USA, Inc..

When did implantable pacemaker Pulse-generator receive FDA 510(k) clearance?

The clearance date for implantable pacemaker Pulse-generator can be found in the official FDA records.

Who is the listed applicant for implantable pacemaker Pulse-generator?

The FDA 510(k) record lists MicroPort CRM USA, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for implantable pacemaker Pulse-generator?

The FDA product code for implantable pacemaker Pulse-generator is DXY. This falls under the Clinical Chemistry category.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑